Showing results (21-30 of 130) with videos related to

Sort By:
Pageof 13
The Oncologist|September 12, 2018
Results from a Monocentric Long-Term Analysis of 23 Patients with Ovarian Sertoli-Leydig Cell TumorsSebastien Gouy, Alexandra Arfi, Amandine Maulard, et al.
Gynecologic Oncology|June 24, 2020
Long term follow-up of a large series of stage-II/III atypical proliferative serous ovarian tumorsSophie Maria, Matthieu Faron, Amandine Maulard, et al.
Gynecologic Oncology|August 24, 2020
A new score based on biomarker values to predict the prognosis of locally advanced cervical cancerAmandine Maulard, Cyrus Chargari, Matthieu Faron, et al.
Annals of Surgical Oncology|November 3, 2020
Results After Conservative Surgery of Stage II/III Serous Borderline Ovarian TumorsSebastien Gouy, Sophie Maria, Matthieu Faron, et al.
Anticancer Research|March 2, 2018
Transitory Stoma at the Time of Complete Cytoreductive Surgery Affects Survival for Patients with Advanced-stage Ovarian CancerGeoffroy Canlorbe, Cyril Touboul, Cyrus Chargari, et al.
Annals of Surgical Oncology|March 26, 2021
Brenner Borderline Ovarian Tumor: A Case Series and Literature ReviewGiulio Ricotta, Amandine Maulard, Catherine Genestie, et al.
Communications Medicine|August 11, 2023
Early-onset gynecological tumors in DNA repair-deficient xeroderma pigmentosum group C patients: a case seriesAndrey A Yurchenko, Brice Fresneau, Bruno Borghese, et al.
Anticancer Research|March 31, 2018
Bevacizumab Does Not Reduce the Lymphocele Rate in Advanced Ovarian Cancer After Complete Cytoreductive SurgeryMorgane Perrin, Enrica Bentivegna, Claire Bonneau, et al.
Therapeutic Advances in Medical Oncology|March 16, 2026
Predictive biomarkers of response to immune checkpoint inhibitors in mismatch repair-deficient endometrial cancerJuan Francisco Grau Béjar, Elisa Yaniz Galende, Catherine Genestie, et al.
Pageof 13